Pharmacists can help fill gaps in care for patients with depression
There are considerable gaps in the care provided for people with depression, which could be addressed by improvements to the GP contract, according to a report published by mental health charities Depression Alliance and SANE to coincide with depression awareness week.
Carol Paton, chief pharmacist at Oxleas NHS Foundation Trust, who provided
advice and guidance during development of the report, told The Journal that several of the issues identified are also relevant for pharmacists.
“There is a huge amount that pharmacists can do to help patients
with depression. The most obvious help that pharmacists can provide is
around
the management of antidepressant drugs. Pharmacists can make sure that
patients who are collecting their first prescription for antidepressants
are aware that there will be a time lag before their symptoms begin to
respond and that the outcome from treatment will be improved if medication
is continued for six months after symptoms have resolved.”
She
added that pharmacists have a valuable role in signposting patients to
local charities and voluntary sector organisations. They could also help
by being aware of the association between depression and chronic physical
health problems such as cardiovascular disease and diabetes. “Pharmacists
should be vigilant to the signs of depression in these patients and encourage
them to speak to their GP so that the condition can be diagnosed and
treated.”
The report “Now we’re talking!” (PDF 610K) details
results from a survey of 450 people with depression. It says that many
inadequacies
in the diagnosis and management of depression were identified during
the survey, especially in ongoing care. The report recommends the inclusion
of quality and outcomes framework indicators that encourage GPs to look
for depression in patients with co-morbidities, to take account of the
broad range of psychological and somatic symptoms associated with depression
when considering a diagnosis, to involve patients when making treatment
decisions, to identify, manage and provide ongoing care, and to provide
information to support adherence to treatment. |